Schizophrenia

>

The HCPLive schizophrenia page is a resource for medical news and expert insights on the mental disorder. This page features expert-led coverage, articles, videos and research on the therapies and development of treatments for schizophrenia, and more.

Latest News

Phase 3 Data Shows Lumateperone Delays Schizophrenia Relapse Longer Than Placebo
Phase 3 Data Shows Lumateperone Delays Schizophrenia Relapse Longer Than Placebo

November 6th 2024

Phase 3 data shows lumateperone 42 mg significantly delayed relapse in patients with schizophrenia vs placebo, with 63% reduced relapse risk and good tolerance.

Phase 3 Data Shows TEV-‘749 Injection Improves Social Function in Schizophrenia
Phase 3 Data Shows TEV-‘749 Injection Improves Social Function in Schizophrenia

November 6th 2024

Psychiatry Month in Review: October 2024
Psychiatry Month in Review: October 2024

November 1st 2024

Bristol Myers Squibb Shares EMERGENT-4, EMERGENT-5 Results on Cobenfy for Schizophrenia
Bristol Myers Squibb Shares EMERGENT-4, EMERGENT-5 Results on Cobenfy for Schizophrenia

November 1st 2024

Study Links Sexual Trauma and Polygenic Scores to Severe Mental Illness
Study Links Sexual Trauma and Polygenic Scores to Severe Mental Illness

October 31st 2024

© 2024 MJH Life Sciences

All rights reserved.